Seeing Is Believing
Currently out of the existing stock ratings of Kerry Holford, 13 are a HOLD (59.09%), 9 are a BUY (40.91%).
Analyst Kerry Holford, currently employed at BERENBERG, carries an average stock price target met ratio of 83.33% that have a potential upside of 15.92% achieved within 182 days.
Kerry Holford’s has documented 38 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 17-Sep-2025.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 12/5/2023. The price target of $94.36 was fulfilled within 1 day with a profit of $1.54 (1.61%) receiving and performance score of 16.06.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 06-Jan-2026
$17.1
6 days ago
(06-Jan-2026)
0/12 (0%)
$-14.32 (-45.58%)
Hold
Since 14-Apr-2022
$16.14
6 days ago
(06-Jan-2026)
0/3 (0%)
$-11.06 (-40.66%)
Buy
Since 02-Dec-2024
$41
$-9.39 (-18.63%)
1 years 1 months 10 days ago
(02-Dec-2024)
1/1 (100%)
$7.82 (23.57%)
182
Hold
Since 12-Nov-2024
$53
1 years 2 months ago
(12-Nov-2024)
4/5 (80%)
$16.8 (46.41%)
412
Buy
Since 17-Mar-2023
1 years 5 months 11 days ago
(01-Aug-2024)
0/13 (0%)
$-16.49 (-43.22%)
Which stock is Kerry Holford is most bullish on?
Which stock is Kerry Holford is most reserved on?
What Year was the first public recommendation made by Kerry Holford?